Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase NA 16Phase 3 10Phase 4 3Phase 1/2 3Phase 1 2

Status

Unknown 37Completed 26Recruiting 8Withdrawn 3Terminated 3Not yet recruiting 3Suspended 1

Sponsor Class

OTHER 130INDUSTRY 67OTHER_GOV 3FED 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Papillomavirus Infections 1Multiple Myeloma 1Burkitt Lymphoma 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 1Prednisone 1Melphalan 1Engerix-B 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Terminated × OTHER_GOV × Clear all
NCT02618109 2022-10-03

LABMI

University Hospital, Angers

Phase 4 Terminated
119 enrolled
Lymphoid

Burkitt Lymphoma

NCT02773550 2020-01-18

Velcadito

Basque Health Service

Phase 4 Terminated
24 enrolled
Plasma cell

Multiple Myeloma

NCT01082861 2010-03-19

TANGO

National Institute for Public Health and the Environment (RIVM)

Phase 4 Terminated

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡